Fight against Ebola
PURE Bioscience, Inc. (OTCQB: PURE) Has Joined Other Top Ebola Stock Movers
With the first recorded ebola death reaching U.S. soil, citizens are becoming more concerned about this deadly disease. As always, investors have looked for stock opportunities to arise from increased media attention. Several companies have seen excellent price action stemming from their health sector involvement and potential ebola treatment participation. Companies like Sanomedica International Hondings, Inc. (OTCQB: SIMH), Lakeland Industries, Inc. (NASDAQ: LAKE), Revolutions Medical Corp. (OTCPK: RMCP), and iBio, Inc. (NYSE: IBIO) have all seen powerful bullish price movement in recent days.
PURE's hard surface disinfectant and food contact surface sanitizer product kills bacteria in just 30 seconds. This is a powerful disinfectant, which can be used to kill pathogens like MRSA, fungi, and even some viruses like HIV, Norovirus, Influenza A, Avian Influenza, and H1N1. Updates on the effects of the disinfectant on the ebola virus have not yet been released. Investors are still waiting for this information. With the recent speculation in the bioscience industry, PURE has developed a great deal of attention from traders, seeing share prices surging as high as $1.20. Accumulation has surged on the speculation, and volume has reached record levels. Additionally, the company just released an update promising to reduce pathogens on leafy greens. The company has released exciting updates to shareholders, which is helping to catalyze this price action. EPA-registered PURE™
Hard Surface disinfectant and food contact surface sanitizer provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial kill times and 24-hour residual protection. PURE Hard Surface completely kills resistant pathogens like MRSA and also effectively eliminates dangerous fungi and viruses including HIV, Norovirus, Influenza A, Avian Influenza and H1N1. PURE Hard Surface is registered for use on food contact surfaces and is gentle enough to be used in childcare environments.
PURE Bioscience (NASDAQ: PURE)
Corporate Overview PURE develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. PURE Bioscience, headquartered in El Cajon, California, (San Diego metropolitan area), was incorporated in 1992.
EPA-registered PURE™ Hard Surface disinfectant and food contact surface sanitizer provides an unparalleled combination of high efficacy and low toxicity with 30-second bacterial kill times and 24-hour residual protection. PURE Hard Surface completely kills resistant pathogens like MRSA and also effectively eliminates dangerous fungi and viruses including HIV, Norovirus, Influenza A, Avian Influenza and H1N1. PURE Hard Surface is registered for use on food contact surfaces and is gentle enough to be used in sensitive children's areas.
SDC: A Platform Technology
Why is SDC unique?
Traditional silver-based disinfectants have very short shelf lives - from hours to days. SDC is a stabilized silver ion complex with a shelf life of several years. The unique bond of the silver ion in SDC allows the silver ion to remain in solution while at the same time making it more bio-available for antimicrobial action.
Mode of Action
SDC kills microorganisms by two modes of action: 1) the silver ion deactivates structural and metabolic membrane proteins leading to microbial death; 2) the microbes view SDC as a food source, allowing the silver ion to enter the microbe. Once inside the organism, the silver ion denatures the DNA, which halts the microbe's ability to replicate and leads to its death. This dual action makes SDC highly and quickly effective against a broad spectrum of microbes.
SDC is non-toxic, non-caustic, colorless, odorless, tasteless and does not produce toxic fumes. While SDC is highly toxic to bacteria, fungus and virus it is non-toxic to humans and animals. Based on the EPA toxicity categorization of antimicrobial products that ranges from Category I (high toxicity) down to Category IV, at use dilutions, SDC is rated in the lowest toxicity category, IV, while traditional disinfectants fall into Categories I and II.
SDC-Based Hard Surface Disinfectant
SDC is the basis for the EPA registered hard surface disinfectant, PURE Hard Surface. Twenty times faster than the leading disinfectants, PURE Hard Surface is the next generation of microbial control. Advantages of SDC include:
- Powerful broad spectrum protection as a disinfectant, fungicide and virucide
Kills germs in 30 seconds
Provides residual protection for 24 hours
Effective against resistant bacteria such as MRSA and VRE
Lowest toxicity rating available
Labeled for use in diverse environments including restaurants, homes, medical facilities, institutions, day care facilities and on children's toys and play areas
PURE Hard Surface Efficacy
SDC as an Additive or Active Ingredient
PURE produces and markets varying strengths of SDC concentrate for use as an additive or active ingredient in other products. PURE pursues strategic development, licensing and distribution agreements with partner companies for the third party products containing SDC as an additive or active ingredient.
SDC for Personal Care
SILVÉRION 2400 Technical Data Sheet
For Samples or to Purchase of SILVÉRION 2400 for personal care use, click here
FDA Regulated SDC-Based Product Development
PURE's SDC technology also shows promise as a broad-spectrum antimicrobial and anti-fungal for use in human and veterinary healthcare products. PURE has initially chosen to pursue approvals through the U.S. Food and Drug Administration (FDA) by partnering with third-party pharmaceutical development companies. Our partner companies assume responsibility for finding and managing the testing and regulatory process for potential FDA regulated SDC-based products. Current product development projects include dermatology, wound care and medical biofilm control products as well as several products for dental industry. An IND for a hand sanitizer is in process.
|Shares Outstanding ||10,900,000 |
|Float ||10,700,000 |
- 1725 Gillespie Way
El Cajon, CA 92020
- 2013 Gateway Conference to Showcase Leading Growth Companies at the Palace Hotel in San Francisco on September 10Marketwired(Thu, Jul 18)
PURE BIOSCIENCE, INC. FinancialsEDGAR Online Financials(Sat, Jun 29)
PURE Bioscience Completes Successful Field Test of PURE Hard Surface Disinfectant With Leading Quick Service Restaurant ChainMarketwired(Thu, Jun 27)
PURE Bioscience Reports Fiscal Third Quarter 2013 ResultsMarketwired(Fri, Jun 14)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online(Fri, Jun 14)
PURE BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Jun 14)
PURE Bioscience Ships Initial Order to Italian Export Consortium, TICEMarketwired(Fri, Jun 7)
PURE Bioscience Appoints Dave Pfanzelter Chairman of the BoardMarketwired(Fri, May 17)
PURE Bioscience Stock to Begin Trading on the OTCQB MarketplaceMarketwired(Fri, May 17)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or StandEDGAR Online(Fri, May 17)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecEDGAR Online(Mon, Apr 29)
PURE Bioscience Receives Favorable NASDAQ Listing DecisionMarketwired(Thu, Apr 25)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, Apr 25)
PURE BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity SecEDGAR Online(Tue, Apr 23)
<a data-cke-saved-href="http://seekingalpha.com/article/1325891-biotechs-ramping-up-on-china-s-avian-flu-outbreak?source=yahoo"; href="http://seekingalpha.com/article/1325891-biotechs-ramping-up-on-china-s-avian-flu-outbreak?source=yahoo"; "="" rel="nofollow" target="_blank">; rel="nofollow">Biotechs Ramping Up On China's Avian Flu Outbreakat Seeking Alpha(Mon, Apr 8)